Cementos Bio-B (SN:CEMENTOS) — Stock Price
Cementos Bio-B (SN:CEMENTOS) is currently trading at CL$1730.00 CLP, up 0.00% today. Over the past 52 weeks, shares have ranged between CL$1591.10 and CL$1826.20. This page tracks Cementos Bio-B's live share price on the SN exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Cementos Bio-B (CEMENTOS) market capitalisation.
Cementos Bio-B (CEMENTOS) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Cementos Bio-B's daily closing share price and trading volume on the SN exchange over the past year, giving a clear view of recent price momentum and liquidity.
Cementos Bio-B Income Statement — Revenue, Profit & Earnings by Year
Cementos Bio-B's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CL$370.54 Billion | CL$359.56 Billion | CL$349.10 Billion | CL$334.00 Billion | CL$289.47 Billion |
| Cost of Revenue | CL$227.64 Billion | CL$222.51 Billion | CL$219.97 Billion | CL$231.03 Billion | CL$187.28 Billion |
| Gross Profit | CL$142.90 Billion | CL$137.05 Billion | CL$129.14 Billion | CL$102.98 Billion | CL$102.19 Billion |
| Research & Development | — | — | — | — | — |
| SG&A | CL$72.09 Billion | CL$72.27 Billion | CL$71.58 Billion | CL$71.11 Billion | CL$65.17 Billion |
| Total Operating Expenses | CL$326.92 Billion | CL$321.46 Billion | CL$314.83 Billion | CL$325.07 Billion | CL$272.82 Billion |
| Operating Income | CL$43.62 Billion | CL$38.11 Billion | CL$34.27 Billion | CL$8.93 Billion | CL$16.65 Billion |
| EBITDA | — | — | — | CL$19.07 Billion | CL$38.71 Billion |
| EBIT | — | — | — | — | CL$17.09 Billion |
| Interest Expense | CL$8.53 Billion | CL$10.22 Billion | CL$13.86 Billion | CL$10.76 Billion | CL$3.26 Billion |
| Income Before Tax | CL$39.67 Billion | CL$40.97 Billion | CL$26.62 Billion | CL$5.64 Billion | CL$33.91 Billion |
| Income Tax Expense | — | — | — | — | CL$6.88 Billion |
| Net Income | CL$33.09 Billion | CL$32.43 Billion | CL$22.80 Billion | CL$10.56 Billion | CL$26.88 Billion |
Cementos Bio-B Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Cementos Bio-B's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CL$528.13 Billion | CL$521.44 Billion | CL$491.32 Billion | CL$475.75 Billion | CL$488.87 Billion |
| Total Current Assets | CL$173.78 Billion | CL$150.06 Billion | CL$145.94 Billion | CL$133.08 Billion | CL$150.65 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CL$1.58 Million | CL$1.61 Million | CL$16.02 Million | CL$2.25 Million | CL$2.26 Million |
| Net Receivables | CL$59.38 Billion | CL$55.99 Billion | CL$56.91 Billion | CL$48.00 Billion | CL$42.21 Billion |
| Inventory | CL$53.76 Billion | CL$50.71 Billion | CL$56.70 Billion | CL$58.94 Billion | CL$40.74 Billion |
| Property, Plant & Equipment | — | — | — | — | CL$289.97 Billion |
| Goodwill | CL$12.48 Billion | CL$12.48 Billion | CL$12.48 Billion | CL$12.48 Billion | CL$12.48 Billion |
| Total Liabilities | CL$239.33 Billion | CL$250.72 Billion | CL$235.01 Billion | CL$234.09 Billion | CL$231.64 Billion |
| Total Current Liabilities | CL$126.09 Billion | CL$116.30 Billion | CL$99.54 Billion | CL$93.58 Billion | CL$81.26 Billion |
| Long-term Debt | CL$63.59 Billion | CL$81.32 Billion | CL$94.70 Billion | CL$97.96 Billion | CL$97.47 Billion |
| Net Debt | CL$48.66 Billion | CL$75.84 Billion | CL$88.50 Billion | CL$92.10 Billion | CL$58.66 Billion |
| Total Stockholder Equity | CL$288.15 Billion | CL$270.07 Billion | CL$255.64 Billion | CL$240.99 Billion | CL$256.56 Billion |
| Retained Earnings | CL$164.51 Billion | CL$141.35 Billion | CL$132.73 Billion | CL$116.77 Billion | CL$134.48 Billion |
Cementos Bio-B Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Cementos Bio-B generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Operating Cash Flow | CL$25.84 Billion | CL$33.56 Billion | CL$30.23 Billion | CL$38.26 Billion | CL$21.74 Billion |
| Capital Expenditures | CL$21.98 Billion | CL$9.34 Billion | CL$12.45 Billion | CL$16.24 Billion | CL$8.52 Billion |
| Free Cash Flow | CL$3.78 Billion | CL$24.23 Billion | CL$17.78 Billion | CL$22.02 Billion | CL$13.22 Billion |
| Investing Cash Flow | CL$5.28 Billion | CL$-8.60 Billion | CL$-13.44 Billion | CL$-6.23 Billion | CL$-8.50 Billion |
| Financing Cash Flow | CL$-30.52 Billion | CL$-5.77 Billion | CL$-31.44 Billion | CL$-17.04 Billion | CL$-49.06 Billion |
| Dividends Paid | CL$22.11 Billion | CL$2.79 Billion | CL$8.29 Billion | CL$13.77 Billion | CL$8.33 Billion |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CL$23.44 Billion | CL$14.40 Billion | CL$13.84 Billion | CL$11.08 Billion | CL$11.09 Billion |
| Change in Cash | CL$665.62 Million | CL$19.18 Billion | CL$-14.24 Billion | CL$15.63 Billion | CL$-35.82 Billion |
Cementos Bio-B Earnings History — EPS Actual vs. Analyst Estimates
Track Cementos Bio-B's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Dec 31, 2025 | 52.17 | — | — |
| Sep 30, 2025 | 26.97 | — | — |
| Jun 30, 2025 | 23.72 | — | — |
| Mar 31, 2025 | 22.37 | — | — |
| Dec 31, 2024 | 35.33 | — | — |
| Sep 30, 2024 | 21.17 | — | — |
| Jun 30, 2024 | 24.67 | — | — |
| Mar 31, 2024 | 41.56 | — | — |